Ze Mi
Impact in
- Biotechnology top 5%
- Cancer Research and Treatments
-
- Nanoplatforms for cancer theranostics
Papers in
-
- Nanoplatforms for cancer theranostics 8
-
- Advanced biosensing and bioanalysis techniques 2
- Co-authors
- Pengfei Rong (20 shared papers)Zhichao Feng (4 shared papers)Wenhu Zhou (6 shared papers)Mengtian Ma (3 shared papers)Zhi-ru Zhu (5 shared papers)Xiao Yang (2 shared papers)Jiahao Liu (7 shared papers)Dingbin Liu (2 shared papers)
In The Last Decade
Ze Mi
27 papers receiving 552 citations
Peers
Comparison fields: 5 of 82
- Biotechnology 121
- Biomedical Engineering 226
- Pharmacology 41
- Biomaterials 46
- Cancer Research 48
Countries citing papers authored by Ze Mi
This map shows the geographic impact of Ze Mi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ze Mi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ze Mi more than expected).
Fields of papers citing papers by Ze Mi
This network shows the impact of papers produced by Ze Mi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ze Mi. The network helps show where Ze Mi may publish in the future.
Co-authors
The 25 scholars most cited alongside Ze Mi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 69 | |
| 2 | 2020 | 67 | |
| 3 | 2019 | 60 | |
| 4 | 2022 | 54 | |
| 5 | 2019 | 52 | |
| 6 | 2015 | 35 | |
| 7 | 2016 | 34 | |
| 8 | 2014 | 34 | |
| 9 | 2022 | 27 | |
| 10 | 2024 | 19 | |
| 11 | 2023 | 16 | |
| 12 | 2022 | 12 | |
| 13 | 2024 | 11 | |
| 14 | 2014 | 11 | |
| 15 | 2024 | 10 | |
| 16 | 2022 | 9 | |
| 17 | 2025 | 6 | |
| 18 | 2022 | 4 | |
| 19 | 2022 | 4 | |
| 20 | 2024 | 3 |
About Ze Mi
Ze Mi is a scholar working on Biomedical Engineering, Molecular Biology, Immunology, Pulmonary and Respiratory Medicine and Surgery, having authored 28 papers that have together received 554 indexed citations. Recurring topics across this work include Nanoplatforms for cancer theranostics (8 papers), Cancer Research and Treatments (4 papers), Neuroscience and Neuropharmacology Research (4 papers), Alzheimer's disease research and treatments (3 papers), Memory and Neural Mechanisms (3 papers), Immune Cell Function and Interaction (3 papers), Advanced biosensing and bioanalysis techniques (2 papers) and MicroRNA in disease regulation (2 papers). The work is most often cited by research in Biotechnology (121 citations), Biomedical Engineering (226 citations), Pharmacology (41 citations), Biomaterials (46 citations) and Cancer Research (48 citations). Ze Mi has collaborated with scholars based in China, Canada and Australia. Frequent co-authors include Pengfei Rong, Zhichao Feng, Wenhu Zhou, Mengtian Ma, Zhi-ru Zhu, Xiao Yang, Jiahao Liu, Dingbin Liu, Shuancheng Ren and Hongpei Tan. Their work appears in journals such as Drug Resistance Updates, Acta Pharmaceutica Sinica B, Neurochemical Research, Journal of Cancer and Neuroscience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.